Document is current
Any future updates will be listed below
-
Authors
Skalicky, Anne M. https://orcid.org/0000-0001-9865-3824
Wang, Yan
Eseyin, Olabimpe R.
Stefan, Marissa
Rane, Pallavi B.
McLaren, Julie
Maurer, Marcus
-
Funding
Funding for this research was provided by:
Amgen (20210254)
- License Information
-
More Information
Article History
Received: 19 August 2024
Accepted: 14 December 2024
First Online: 24 December 2024
Declarations
:
: Not applicable.
: Not applicable.
: AMS, ORE, and MS are employees of Evidera. Evidera received funding from Amgen to conduct the study. JM, PBR, and YW are employees of Amgen and own shares of Amgen stock. MM has no conflicts of interest in relation to this work. Outside of it, MM is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Amgen, Aralez, ArgenX, AstraZeneca, Celldex, Centogene, CSL Behring, FAES, Genentech, GIInnovation, GSK, Innate Pharma, Kyowa Kirin, Leo Pharma, Eli Lilly, Menarini, Moxie, Novartis, Pfizer, Roche, Sanofi/Regeneron, Third Harmonic Bio, UCB, and Uriach.
